Pharmafile
Therapeutic areas in focus
New but controversial ALS drug, Relyviro, approved by FDA
Bio-Rad and Qiagen plan to merge in a deal potentially worth over $10bn
FDA approves AstraZeneca's liver cancer treatment
FDA approves Furosemide to treat patients with chronic heart failure
New cancer vaccine may be available by 2030
Johnson & Johnson is planning to acquire Abiomed for $17bn
Gilead Sciences and Macrogenics partner for bispecific antibody development
FDA recalls two blood pressure pills due to risk that they may cause cancer
FDA approves GSK's whooping cough vaccine, Boostrix, for use in pregnant patients
New pill which may halt cancer is given to first patient in a trial
Aaron Bean at Veeva explores the challenges of rare diseases: With up to 30 million people in EU living with rare diseases, Veeva discusses the challenges facing these rare diseases
Pharmafile Events 2022-2023